206 related articles for article (PubMed ID: 24466195)
1. CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.
Okamoto T; Iwata S; Yamazaki H; Hatano R; Komiya E; Dang NH; Ohnuma K; Morimoto C
PLoS One; 2014; 9(1):e86671. PubMed ID: 24466195
[TBL] [Abstract][Full Text] [Related]
2. CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.
Komiya E; Ohnuma K; Yamazaki H; Hatano R; Iwata S; Okamoto T; Dang NH; Yamada T; Morimoto C
Biochem Biophys Res Commun; 2014 May; 447(4):609-15. PubMed ID: 24747072
[TBL] [Abstract][Full Text] [Related]
3. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.
Amatya VJ; Takeshima Y; Kushitani K; Yamada T; Morimoto C; Inai K
Oncol Rep; 2011 Dec; 26(6):1369-75. PubMed ID: 21894438
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
Okamoto T; Yamazaki H; Hatano R; Yamada T; Kaneko Y; Xu CW; Dang NH; Ohnuma K; Morimoto C
Biochem Biophys Res Commun; 2018 Oct; 504(2):491-498. PubMed ID: 30197002
[TBL] [Abstract][Full Text] [Related]
6. CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma.
Amatya VJ; Takeshima Y; Aoe K; Fujimoto N; Okamoto T; Yamada T; Kishimoto T; Morimoto C; Inai K
Oncol Rep; 2013 Jan; 29(1):21-8. PubMed ID: 23128478
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
[TBL] [Abstract][Full Text] [Related]
8. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription.
Yamada K; Hayashi M; Madokoro H; Nishida H; Du W; Ohnuma K; Sakamoto M; Morimoto C; Yamada T
PLoS One; 2013; 8(4):e62304. PubMed ID: 23638030
[TBL] [Abstract][Full Text] [Related]
10. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.
Goparaju C; Donington JS; Hsu T; Harrington R; Hirsch N; Pass HI
J Thorac Oncol; 2013 Sep; 8(9):1203-11. PubMed ID: 23887168
[TBL] [Abstract][Full Text] [Related]
12. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
13. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
15. CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells.
Hirano T; Higuchi T; Katsuragawa H; Inoue T; Kataoka N; Park KR; Ueda M; Maeda M; Fujiwara H; Fujii S
Mol Hum Reprod; 1999 Feb; 5(2):168-74. PubMed ID: 10065873
[TBL] [Abstract][Full Text] [Related]
16. Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition.
Srikanth M; Das S; Berns EJ; Kim J; Stupp SI; Kessler JA
Neuro Oncol; 2013 Mar; 15(3):319-29. PubMed ID: 23328812
[TBL] [Abstract][Full Text] [Related]
17. [Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule].
Morimoto C; Ohnuma K
Gan To Kagaku Ryoho; 2016 Jul; 43(7):855-62. PubMed ID: 27431629
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.
Kim MC; Cui FJ; Kim Y
Asian Pac J Cancer Prev; 2013; 14(6):3625-30. PubMed ID: 23886156
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.
Podergajs N; Motaln H; Rajčević U; Verbovšek U; Koršič M; Obad N; Espedal H; Vittori M; Herold-Mende C; Miletic H; Bjerkvig R; Turnšek TL
Oncotarget; 2016 Jan; 7(1):593-609. PubMed ID: 26573230
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines.
Abe M; Havre PA; Urasaki Y; Ohnuma K; Morimoto C; Dang LH; Dang NH
BMC Cancer; 2011 Feb; 11():51. PubMed ID: 21284881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
